Antiverse raised €8.0M in a Series A round in Mar 2026. The company is based in Cardiff, UK. Investors in the round: DBW, DOMiNO Ventures, i&i Biotech Fund and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
